Chou, M.-H.; Chuang, H.-C.; Lin, Y.-T.; Tsai, M.-H.; Kao, Y.-H.; Lin, I.-C.; Huang, T.-L.; Fang, F.-M.; Chien, C.-Y.
Targeting mTOR-CCL20 Signaling May Improve Response to Docetaxel in Head and Neck Squamous Cell Carcinoma. Int. J. Mol. Sci. 2021, 22, 3046.
https://doi.org/10.3390/ijms22063046
AMA Style
Chou M-H, Chuang H-C, Lin Y-T, Tsai M-H, Kao Y-H, Lin I-C, Huang T-L, Fang F-M, Chien C-Y.
Targeting mTOR-CCL20 Signaling May Improve Response to Docetaxel in Head and Neck Squamous Cell Carcinoma. International Journal of Molecular Sciences. 2021; 22(6):3046.
https://doi.org/10.3390/ijms22063046
Chicago/Turabian Style
Chou, Ming-Huei, Hui-Ching Chuang, Yu-Tsai Lin, Ming-Hsien Tsai, Ying-Hsien Kao, I-Chun Lin, Tai-Lin Huang, Fu-Min Fang, and Chih-Yen Chien.
2021. "Targeting mTOR-CCL20 Signaling May Improve Response to Docetaxel in Head and Neck Squamous Cell Carcinoma" International Journal of Molecular Sciences 22, no. 6: 3046.
https://doi.org/10.3390/ijms22063046
APA Style
Chou, M. -H., Chuang, H. -C., Lin, Y. -T., Tsai, M. -H., Kao, Y. -H., Lin, I. -C., Huang, T. -L., Fang, F. -M., & Chien, C. -Y.
(2021). Targeting mTOR-CCL20 Signaling May Improve Response to Docetaxel in Head and Neck Squamous Cell Carcinoma. International Journal of Molecular Sciences, 22(6), 3046.
https://doi.org/10.3390/ijms22063046